Antitumor effects of polynucleotides and theophylline.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002478:Cells, Cultured; D003470:Culture Media; D005260:Female; D007109:Immunity / Q000528:radiation effects; D007274:Injections, Intraperitoneal; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology; D010726:Phosphodiesterase Inhibitors; D011063:Poly A-U / Q000494:pharmacology / Q000627:therapeutic use; D011070:Poly I-C / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011119:Polynucleotides / Q000627:therapeutic use*; D011830:Radiation Effects; D011925:Rauscher Virus; D013806:Theophylline / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D003470:Culture Media; D010726:Phosphodiesterase Inhibitors; D011119:Polynucleotides; D011063:Poly A-U; D013806:Theophylline; D011070:Poly I-C